Waterborne disease is emerging as a significant and growing public health threat across both...
Category - Policy, Ethics & Regulation
Bayer receives Breakthrough Therapy Designation for sevabertinib...
Bayer has received Breakthrough Therapy Designation in the United States and China for sevabertinib...
University of Stirling Uses Immersive Pandemic Simulation to...
The University of Stirling has introduced an immersive pandemic simulation designed to prepare...
Elsevier Report Finds One in Three Corporate Researchers Have...
Elsevier’s latest global study, Researcher of the Future, reveals that one-third (33%) of corporate...
Scientists Develop AI-Driven Tool to Help Manage Pressure Ulcers
Pressure ulcers, also known as bedsores, are one of the top ten harms in the NHS, affecting up to...
Hikma and Celltrion deepen biosimilar partnership to broaden...
Hikma Pharmaceuticals PLC and Celltrion Healthcare Co., Ltd. have announced a new phase in their...
UK biotech investment remains resilient in H1 2025, says BIA...
The UK’s biotech sector has demonstrated resilience in the first half of 2025, according to the...
Koselugo Recommended for EU Approval in Adults with NF1...
AstraZeneca’s Koselugo (selumetinib) has secured a positive recommendation from the European...
Enhertu plus pertuzumab granted FDA Priority Review as potential...
AstraZeneca and Daiichi Sankyo have announced that the US Food and Drug Administration (FDA) has...
Case Study: PostNord TPL ensures GDP compliance with Vaisala’s...
PostNord TPL, part of the PostNord Group, operates one of the largest third-party logistics...